EVOKE PHARMA, INC. Proceeds from Stock Options Exercised
EVOKE PHARMA, INC. reported Proceeds from Stock Options Exercised of $45.45 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-03-21
- EVOKE PHARMA, INC. proceeds from stock options exercised for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- EVOKE PHARMA, INC. proceeds from stock options exercised for the quarter ending 2021-09-30 was $0.00.
- EVOKE PHARMA, INC. proceeds from stock options exercised for the quarter ending 2020-12-31 was $213.19K.
- EVOKE PHARMA, INC. proceeds from stock options exercised for fiscal 2021 was $45.45K, a 78.94% decline from fiscal 2020.
- EVOKE PHARMA, INC. proceeds from stock options exercised for fiscal 2020 was $215.82K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month | Proceeds from Stock Options Exercised 80 month | Proceeds from Stock Options Exercised 83 month | Proceeds from Stock Options Exercised 86 month |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | $0.00 derived: sum of 2 quarters · filed 2023-03-21 | $45.45K 10-K · filed 2023-03-21 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $45.45K 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | $45.45K 10-Q · filed 2022-08-10 | ||||||
| 2020-12-31 | $213.19K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $215.82K 10-K · filed 2022-03-08 | |||||
| 2020-09-30 | $2.63K 10-Q · filed 2021-11-10 | ||||||
| 2014-03-31 | $101.36K 10-Q · filed 2014-05-13 | ||||||
| 2013-12-31 | $101.36K 10-K · filed 2014-03-25 | ||||||
| 2013-09-30 | $101.36K 10-Q · filed 2013-11-13 |